Continuous administration of ramosetron with patient-controlled analgesia after laparoscopic distal gastrectomy does not delay postoperative bowel function recovery: A prospective, randomized, double-blinded study

BACKGROUND: Currently, 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists are indicated to slow gastrointestinal motility in the diarrhea-predominant subtype of irritable bowel syndrome. They are commonly used to prevent or treat postoperative nausea and vomiting (PONV) and opioid-induced nause...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Hong Soo, Huh, Jaewon, Kim, Youngchan, Hong, Sang Hyun, Lee, Jaemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081143/
https://www.ncbi.nlm.nih.gov/pubmed/30075513
http://dx.doi.org/10.1097/MD.0000000000011503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081143/
https://www.ncbi.nlm.nih.gov/pubmed/30075513
http://dx.doi.org/10.1097/MD.0000000000011503

Ejemplares similares